Pay in 4 interest-free payments of $29003.25 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
NDC: 00766-0801-55
a leader in ophthalmic solutions
forcing the extra insulin (and bubbles) back into the vial
Packaged in a convenient set of five 2 mL vials
or first-aid kit to use in case of emergencies
Synagis palivizumab 50mg/0.5 mL Single-Dose Vial Santare chhilaka NDC: 00766-0801-55Synagis palivizumab 50mg 0. 5 mL Single Dose Vial is a highly effective medication used for the prevention of serious respiratory tract infections caused by the respiratory syncytial virus (RSV) in infants and children. RSV is a common virus that can lead to severe respiratory infections in young children, particularly those with weakened immune systems. Synagis palivizumab, with its active ingredient 50mg of palivizumab, is administered by injection
